An outcome at a time
GHK-Cu research: skin, hair and wound measurements
A person can want firmer skin, more hair or a healed wound. Those are different ambitions, and the experiments have measured different pieces of them.
Copper peptide skin studies
The skin-regeneration review gathers small human topical studies reporting improvements in firmness, density, fine lines and wrinkle depth. It also reports increased collagen production in 70% of GHK-Cu-treated women, compared with 50% for vitamin C and 40% for retinoic acid. These percentages describe the share showing a response; 70% does not describe how much extra collagen each person made.
The larger-sounding interpretation is easy to imagine from those percentages. The interesting next measurement would connect that response in people to something visible or felt. The post-laser trial that opens this site measured redness and satisfaction instead, with different conclusions for each. There is room for more than one useful outcome here.
Skin outcomes
Collagen production, skin density, firmness and wrinkle depth each describe a particular measurement. The review combines laboratory work with small topical human studies; it does not establish whole-body rejuvenation.
Copper peptide benefits
The most directly relevant human findings concern topical skin preparations and the GHK combination used in the hair trial below. The broader repair claims reach well beyond these populations and outcomes.
Copper peptide vs retinol
The comparison above used retinoic acid. The 2025 review of topical GHK discusses that collagen finding and the problem of getting GHK through the skin barrier. The popular ‘copper peptide vs retinol’ question is wider than the experiment: it asks for an overall winner across appearance, tolerability and skin needs.
I wouldn't rank every skin treatment from this collagen comparison. A fairer question is which outcome a particular preparation improved under the conditions actually studied. That is already interesting enough to justify the small clinical studies without turning them into a universal preference.
The retinoic acid comparator
The 40% comparator refers to retinoic acid in the reported collagen comparison. It gives no overall ranking for every product described as retinol.
Copper peptide hair research
A 6-month randomized study in 45 men with androgenetic alopecia tested a complex of 5-aminolevulinic acid and GHK. Mean hair-count increases were 52.6 at 100 mg/mL and 71.5 at 50 mg/mL, versus 9.6 with placebo. No adverse events were reported in any group.
The lower active concentration had the larger mean increase. Those reversed averages spoil any simple stronger-means-better account for me. More fundamentally, the study tested a combination, so its result leaves the contribution of GHK alone unresolved.
Earlier peptide-copper experiments in C3H mice reported stimulation of hair-follicle activity. Those animal results supply a reason to investigate; the human combination trial supplies a count in people. Neither establishes a timetable for pure GHK-Cu hair regrowth or demonstrates DHT blocking.
Hair counts
The human endpoint was hair-count change over the trial's 6-month duration. A fuller-looking scalp reported in a forum has a different evidential status.
Copper Tripeptide-1 for hair
That cosmetic ingredient name refers to GHK-Cu. The trial above investigated 5-aminolevulinic acid plus GHK, which limits claims made for the copper complex on its own.

Wound closure and repair materials
The wound literature becomes tangible when a peptide meets a material. A biotinylated GHK collagen matrix accelerated dermal wound healing in rats. In a separate cell-culture study, GHK-modified alginate hydrogels increased repair-factor secretion from human mesenchymal stem cells, including VEGF, which supports blood-vessel growth.
A composite scaffold with GHK-Cu and bioglass improved human dermal fibroblast viability in vitro and showed antibacterial activity in laboratory tests. More recent GHK nanofibers in a hyaluronic-acid hydrogel were investigated in mouse wounds and human fibroblast cultures. These findings involve modified peptides, carriers and composite materials.
I'd like this line of work to succeed because an actual wound is a concrete problem. Establishing a useful human dressing requires human wound outcomes; the materials experiments described here remain largely preclinical.
Rat behaviour and neuroprotection
The rat study of pain-induced aggressive-defensive behaviour used free GHK and recorded reduced attack frequency. It concerns rat behaviour under experimental conditions. Human cognitive benefit and entry of GHK-Cu into the human brain remain unestablished.
For the much larger anti-aging argument, the gene-expression analysis offers hypotheses that still need validation in living tissue. After the modest and oddly divided post-laser result, a reproducible human endpoint feels like a more useful ambition to me.